China, European Union, Germany, Global, United Kingdom, USA - February 8 2022
The political and policy focus on drug prices continues in 2022 in key markets across the globe. In particular, in the U.S., UK, and EU, policymakers…
Zina Chatzidimitriadou, Patricia DeLoatche, Maria Isabel Manley, Anna-Shari Melin, Maarten Meulenbelt, Rebecca K. Wood, Chen Yang
USA - October 18 2017
Earlier this month, California passed two bills with significant implications for pharmaceutical manufacturers: one imposing prescription drug price…
William A. Sarraille, Trevor L. Wear
USA - July 14 2015
A recent opinion examines the interplay between the Health Insurance Portability and Accountability Act ("HIPAA") and the False Claims Act ("FCA")…
Catherine Kim, Scott D. Stein
European Union, United Kingdom, USA - January 13 2022
The global life sciences industry is evolving at an extraordinary rate. Scientists are rapidly gaining insights into…
Jim Badke, William Blumenthal, Raymond A. Bonner, Colleen Theresa Brown, Marinn Carlson, Elizabeth C. Curtin, Meng Ding, Joshua G. DuClos, Sharon R. Flanagan, Carlton Fleming, Ching-Lee Fukuda, Elizabeth Hardcastle, Patrick J. Harrison, Joshua T. Hofheimer, James R. Johnson, Jaime L.M. Jones, Paul E. Kalb, Karen Kazmerzak, Coleen Klasmeier, Lei Li, William RM Long, David J. Ludlow, Maria Isabel Manley, Donielle McCutcheon, Maarten Meulenbelt, Eva von Mühlenen, Raj D. Pai, Frank Rahmani, Tatjana Sachse, William A. Sarraille, Dorothee Schramm, Josefine Sommer, Catherine Y. Starks, Adriana V. Tibbitts, Trevor L. Wear, Rebecca K. Wood, Chen Yang, Friven Yeoh, Oliver Zhong
USA - August 27 2020
In almost the first three quarters of 2020, the U.S. Department of Health and Human Services, Office for Civil Rights (“OCR”) has settled three cases…
Colleen Theresa Brown, Rina Mady, Megan Svedman